Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | X026330 | — |
No symptoms. No additional AE; HCP reported improperly stored administered MMR II; This spontaneous report was received from a Physician Assistant (Medical assistant) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 21-APR-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Injection, 0.5 mL, administered as prophylaxis (lot number X026330 has been verified to be valid for Measles, Mumps, and Rubella [Wistar RA 27-3] Virus Vaccine, Live [M-M-R II], expiration date 07-NOV-2025; route of administration, anatomical site of injection and vaccination scheme frequency were not provided), which was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (expiration date, and lot number were not reported). The dose was administered after a temperature excursion (TE) at 8.5 degree Celsius (C) for 4 minutes, with no previous TE (Product storage error). No symptoms and no additional adverse events (AE) were reported for the patient.
Sterile diluent